Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • bjackson
    Junior Member
    • May 2015
    • 6

    #1

    Normalization and analysis of proteomic spectral count data

    I have spectral count data (SomaScan proteomics read).

    What I have is protein name / uniprot identifier and a count (e.g., 188.9 or 106219.5).

    I wanted to use PLGEM in R / bioconductor to analyze the data for differential expression between groups, but it says that 'normalized' data is required. Does anyone have a recommendation of what type of normalization to do?

    I can't do something like dNSAF since I only have counts for called proteins, not counts for peptides.

    Thanks.

    Update: I've seen two thoughts on normalization, horizontal and vertical
    one would be to normalize across samples (eg divide all protein counts by the total protein count for that sample so that that normalizes to the total protein load)

    The other would be to normalize across each protein (e.g. mean 0, sd 1, so highly expressed proteins don't have an outsized effect on the significance levels)

    You could even do the first then the second. Is there any good reason to to either or both?
    Last edited by bjackson; 05-08-2015, 01:45 PM.

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 11:13 AM
0 responses
19 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, Yesterday, 10:48 AM
0 responses
18 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
36 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
42 views
0 reactions
Last Post SEQadmin2  
Working...